Trial Profile
Retrospective patient experience study of DEXTENZA following cataract surgery.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Mar 2017
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary)
- Indications Ocular inflammation; Ocular pain; Postoperative inflammation; Postoperative pain
- Focus Therapeutic Use
- 21 Mar 2017 New trial record
- 15 Mar 2017 According to an Ocular Therapeutics media release, data from this trial were published in Patient Preference and Adherence.
- 15 Mar 2017 Results published in an Ocular Therapeutics media release.